Latest Thrombolysis Stories
People with a history of stroke or diabetes who were given clot-busting drugs to break up blood clots after stroke fared better than those who did not receive the drugs.
A targeted, nanoparticle gelatin-based clot-busting treatment dissolved significantly more blood clots than a currently used drug in an animal study of acute coronary syndrome.
Patients who had a transient ischaemic attack (TIA), sometimes referred to as a "mini stroke", were much less likely to experience further vascular events in the first year if their care was co-ordinated by a special hospital team.
Patients who live in rural areas may have a new option for stroke care that doesn't involve traveling long distances.
Considerable regional differences exist in the treatment of patients with acute cerebral infarction.
The percentage of graduating neurology residents comfortable treating stroke with a clot-busting drug has increased dramatically over the past 10 years.
A citywide study published online in todayâ€™s issue of Stroke: Journal of the American Heart Association demonstrates racial disparities in the use of clot-busting drugs to treat acute ischemic stroke, the most common type of stroke.
In a review of nationwide hospital databases, University of Cincinnati (UC) emergency medicine and neurology researchers have found that the rate of treatment with the standard therapy for acute ischemic stroke patients has doubled since 2005.
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 â€” but is still low.
- The word or words serving to define another word or expression, as in a dictionary entry.